DTIL vs MA · rev $10.8M vs P/E 38, rev $17.68B
Precision BioSciences Inc (DTIL) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Precision BioSciences Inc (DTIL) is a biotechnology company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported DTIL revenue for 2026-06-30 was $10.8M. Net income was -$51.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. DTIL currently screens at market cap $48.1M.
Latest reported MA revenue for 2026-06-30 was $17.68B. Net income was $8.27B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
DTIL currently screens at market cap $48.1M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the DTIL and MA stock pages for the full models.
Not investment advice.